Ballentine Partners’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Sell |
2,115
-21
| -1% | -$2.89K | ﹤0.01% | 700 |
|
|
2025
Q1 | $385K | Sell |
2,136
-9
| -0.4% | -$1.62K | 0.01% | 536 |
|
|
2024
Q4 | $336K | Buy |
2,145
+56
| +3% | +$8.77K | 0.01% | 558 |
|
|
2024
Q3 | $380K | Hold |
2,089
| – | – | 0.01% | 505 |
|
|
2024
Q2 | $384K | Buy |
2,089
+9
| +0.4% | +$1.65K | 0.01% | 475 |
|
|
2024
Q1 | $370K | Hold |
2,080
| – | – | 0.01% | 475 |
|
|
2023
Q4 | $258K | Hold |
2,080
| – | – | 0.01% | 550 |
|
|
2023
Q3 | $241K | Hold |
2,080
| – | – | 0.01% | 496 |
|
|
2023
Q2 | $244K | Buy |
+2,080
| New | +$244K | 0.01% | 494 |
|